Welcome to our searchable resource and literature collection on safer supply and related topics.
Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.
Resources
Handout | 2022
Harm reduction, Indigenous
We present findings from a scoping review of qualitative studies on experiences of PWUD with SCS published between 1997 and 2022.
Scoping review | 2023
About PWUD, Barriers and enablers, SCS/OPS
Using insights developed from the ‘ontological turn’ and approaches to co-production from public health and science and technology studies, we explore the multiple relations that come to produce an
Original research | 2022
Drug checking, Illegal drugs, Peer/PWLLE program involvement, About PWUD
Video | 2022
Stigma, Parents/caregivers, About PWUD, Indigenous, About prescribers
Guide or handbook | 2020
Harm reduction, Peer/PWLLE program involvement, Policy/Regulatory
Report | 2022
Evidence base, Safer supply, About PWUD, Outcomes
During the COVID-19 pandemic, overdose rates substantially increased in the United States.
Original research | 2022
About PWUD, Illegal drugs, Housing, 2SLGBTQI+
This analysis sought to identify factors associated with methadone maintenance treatment (MMT) discontinuation among adolescents and young adults (AYA).
Original research | 2022
About PWUD, Youth, Substitution/OAT
Injecting drugs alone limits the potential for intervention and has accounted for a significant proportion of overdose deaths, yet the practice remains understudied.
Original research | 2022
About PWUD, Indigenous, Sex/Gender , Injecting drugs, Illegal drugs
Guidelines | 2022
Clinical guidance, About prescribers
Commentary | 2022
Decriminalization/legalization, Hallucinogens/psychedelics, Policy/Regulatory
We examined measures of drug enforcement as predictors of next-year fatal overdose rates in the Washington/Baltimore High Intensity Drug Trafficking Area (W/B HIDTA).
Original research | 2022
Legal system/law enforcement, Overdose, Mortality, Outcomes, Illegal drugs
This paper explores the narratives of service users of contemporary methadone maintenance treatment services (MMT) in the Republic of Ireland to obtain their perspectives in the context of them neg
Original research | 2022
Substitution/OAT, About PWUD, Barriers and enablers
To investigate whether low barrier MOUD improved retention in care compared to traditional treatment.
Original research | 2022
Barriers and enablers, About PWUD, Substitution/OAT
We test a conceptual model that emphasizes indirect, mediated effects among key factors related to HIV testing in substance use disorder treatment organizations (SUTs), a critical evidence-based pr
Original research | 2022
Evidence base, Wrap-around services
Page Web | 2022
la politique / le cadre de réglementation
This study aimed to determine the feasibility and safety of a tapering dose of lisdexamfetamine for the treatment of acute methamphetamine (MA) withdrawal.
Original research | 2022
Stimulants, Withdrawal, Clinical guidance
We explored whether patients with benzodiazepine exposure at treatment entry would have similar 12-month retention compared to those without benzodiazepine exposure.
Original research | 2022
Substitution/OAT, Clinical guidance
The therapeutic benefits of cannabinoids remain unclear, especially when weighted against their adverse effects.
Lit review | 2022
Withdrawal, Clinical guidance
